S&P 500   4,443.11
DOW   34,869.37
QQQ   370.35
S&P 500   4,443.11
DOW   34,869.37
QQQ   370.35
S&P 500   4,443.11
DOW   34,869.37
QQQ   370.35
S&P 500   4,443.11
DOW   34,869.37
QQQ   370.35

Vycor Medical Stock Forecast, Price & News

0.00 (0.00 %)
(As of 09/27/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Average Volume17,760 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive VYCO News and Ratings via Email

Sign-up to receive the latest news and ratings for Vycor Medical and its competitors with MarketBeat's FREE daily newsletter.

Vycor Medical logo

About Vycor Medical

Vycor Medical, Inc. engages in the provision of innovative surgical and therapeutic solutions to the medical community. It operates through the Vycor Medical and NovaVision segments. The Vycor Medical segment focuses on devices for neurosurgery. The NovaVision segment offers neuro stimulation therapies and diagnostic devices for the treatment and screening of vision field loss. The company was founded by Heather N. Vinas and Heather N. Jensen on June 17, 2005 and is headquartered in Boca Raton, FL.


See More Headlines

Industry, Sector and Symbol

Medical Devices
Current Symbol
Year Founded

Sales & Book Value

Annual Sales





Next Earnings Date
Not Optionable


Overall MarketRank

0.85 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Vycor Medical (OTCMKTS:VYCO) Frequently Asked Questions

What stocks does MarketBeat like better than Vycor Medical?

Wall Street analysts have given Vycor Medical a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Vycor Medical wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How were Vycor Medical's earnings last quarter?

Vycor Medical, Inc. (OTCMKTS:VYCO) announced its quarterly earnings results on Monday, August, 17th. The medical device company reported ($0.01) earnings per share (EPS) for the quarter. The medical device company had revenue of $0.24 million for the quarter.
View Vycor Medical's earnings history

How has Vycor Medical's stock been impacted by Coronavirus?

Vycor Medical's stock was trading at $0.0751 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, VYCO shares have increased by 99.7% and is now trading at $0.15.
View which stocks have been most impacted by COVID-19

Who are Vycor Medical's key executives?

Vycor Medical's management team includes the following people:
  • Adrian Christopher Liddell, Chairman & Chief Financial Officer
  • Peter C. Zachariou, Chief Executive Officer, Director & Executive VP
  • David Marc Cantor, President & Director

What other stocks do shareholders of Vycor Medical own?

What is Vycor Medical's stock symbol?

Vycor Medical trades on the OTCMKTS under the ticker symbol "VYCO."

How do I buy shares of Vycor Medical?

Shares of VYCO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Vycor Medical's stock price today?

One share of VYCO stock can currently be purchased for approximately $0.15.

How many employees does Vycor Medical have?

Vycor Medical employs 6 workers across the globe.

What is Vycor Medical's official website?

The official website for Vycor Medical is www.vycormedical.com.

Where are Vycor Medical's headquarters?

How can I contact Vycor Medical?

Vycor Medical's mailing address is 951 Broken Sound Pkwy NW Ste 320, BOCA RATON, FL 33487-3531, United States. The medical device company can be reached via phone at (561) 558-2000.

This page was last updated on 9/28/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.